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Abstract.  Duchenne's muscular dystrophy (DMD) is 
caused by the absence or drastic decrease of the struc- 
tural protein,  dystrophin,  and is characterized by sar- 
colemmal lesions in skeletal muscle due to the stress 
of contraction.  Dystrophin has been localized to the 
sarcolemma,  but its organization  there is not known. 
We report immunofluorescence studies which show 
that dystrophin is concentrated,  along with the major 
muscle isoform of/3-spectrin,  in three distinct domains 
at the sarcolemma:  in elements overlying both I bands 
and M  lines, and in occasional strands running  along 
the longitudinal  axis of the myofiber. Vinculin,  which 
has previously been found at the sarcolemma overlying 
the I bands and in longitudinal  strands,  was present in 
the same three structures as spectrin and--dystrophin. 
Controls demonstrated that the labeling was intracellu- 
lar.  Comparison to labeling of the lipid bilayer and of 
the extracellular matrix  showed that the labeling for 
spectrin and dystrophin is associated with the intact 
sarcolemma and is not a result of processing artifacts. 
Dystrophin is not required for this lattice-like organiza- 
tion,  as similar domains containing  spectrin but not 
dystrophin are present in muscle from the mdx mouse 
and from humans with Duchenne's muscular dystrophy. 
We discuss the possibility that dystrophin and spectrin, 
along with vinculin,  may function to link the contrac- 
tile apparatus to the sarcolemma of normal skeletal 
muscle. 
UCHENNE'S muscular  dystrophy (DMD) t is  a  rela- 
tively common X-linked  disorder characterized  by 
progressive loss of muscle tissue due to the degrada- 
tion of myofibers. DMD is caused by the lack of dystrophin, 
a high  (•400  kD) molecular weight protein encoded by a 
gene on the X chromosome (Hoffman et al.,  1987, 1988). 
Damaged muscle fibers from patients  with DMD show le- 
sions of the sarcolemma and underlying sarcoplasm (Mokri 
and Engel,  1975; Carpenter and Karpati,  1979) which result 
from the stress of  contraction (Florence et al., 1985; Webster 
et al., 1988). Dystrophin has been found at the sarcolemma 
by immunofluorescence  and  immunoelectron  microscopy 
(Arahata et al.,  1988; Bonilla et al.,  1988a; Watkins et al., 
1988;  Zubrzycka-Gaarn  et al.,  1988;  Byers et al.,  1991; 
Ohlendieck et al.,  1991; Wakayama and Shibuya,  1991). It 
has thus been proposed that dystrophin  stabilizes  the sar- 
colemma (Beam, 1988), but how it does so has not been de- 
termined. 
Dystrophin's  primary sequence resembles those of spec- 
trin  and  ot-actinin,  suggesting  that  these proteins  can  be 
grouped into a super family of cytoskeletal proteins (Davi- 
son and Critchley,  1988; Koenig et al., 1988). Spectrins are 
high molecular weight molecules first discovered in erythro- 
cytes  and  subsequently  found  in  most  mammalian  cells 
1. Abbreviation used in this paper: DMD, Duchenne's muscular dystrophy. 
(Marchesi,  1985; Morrow,  1989; Bennett,  1990). In the red 
blood cell, spectrin oligomers are the major component of 
a sub-membrane network involved in maintaining  the dis- 
tinctive biconcave shape of the cell and in organizing integral 
membrane proteins in the plasmalemma (Marchesi,  1985; 
Bennett,  1990). This model of spectrin-membrane organiza- 
tion has been proposed to apply to other cells containing 
spectrin.  For example, this laboratory has previously shown 
by immunoelectron  microscopy that dystrophin  (Dmytrenko 
et al., manuscript submitted for publication)  and an unusual 
isoform of B-spectrin  (Bloch and Morrow,  1989; Pumplin, 
D. W., J. C. Strong, J. G. Krikorian,  G. A. Porter, and J. C. 
Winkelmann,  1990; J.  Cell Biol.  111:165a) are present in a 
similar sub-membrane network that helps to organize acetyl- 
choline receptors in the membrane of cultured mammalian 
myotubes. In adult myofibers, dystrophin  and spectrin have 
previously been localized by immunofluorescence  to the sar- 
colemma at the neuromuscular junction and in extrajunc- 
tional regions (Repasky et al., 1982; Craig and Pardo,  1983; 
Nelson and Lazarides,  1983; Appleyard  et al.,  1984; Ara- 
hata et al., 1988; Bonilla et al., 1988a; Watldns et al., 1988; 
Zubrzycka-Gaarn et al.,  1988;  Bloch and  Morrow,  1989; 
Chang et al., 1989; Shimizu et al., 1989; Byers et al., 1991; 
Ohlendieck et al.,  1991; Pons et al.,  1991; Sealock et al., 
1991; Yeadon et al.,  1991), and dystrophin  has been ob- 
served in a cytoskeletal network in ultrastructural  experi- 
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may therefore contribute to a sub-sarcolemmal network in 
the adult myofiber. 
We have addressed this possibility by determining if dys- 
trophin and  spectrin  codistribute under the  sarcolemma. 
Previous reports (Repasky et al.,  1982;  Nelson and Laza- 
rides, 1983) have demonstrated that spectrin is enriched in 
skeletal myofibers in a  sub-sarcolemmal, two-dimensional 
lattice containing longitudinal strands, transverse elements 
over  the  M  lines,  and  "costameres"regions  of the  sar- 
colemma that overlie the I bands flanking the Z lines (Craig 
and Pardo, 1983; Pardo et al., 1983a).  Costameres may be 
a link between the sarcolemma and the contractile apparatus 
(Garamv61gyi, 1965; Chiesi et al., 1981; Pierobon-Bormioli, 
1981; Craig and Pardo, 1983; Pardo et al., 1983a,b; Street, 
1983; Shear and Bloch, 1985).  To determine if both dystro- 
phin and fl-spectrin are  present in  costameres  and other 
sub-sarcolemmal domains, we used antibodies against dys- 
trophin and the major muscle isoform of/3-spectrin (Winkel- 
mann et al., 1990b) to study the distribution of  these proteins 
in frozen sections of rat skeletal muscle. Fibers sectioned 
tangentially to reveal  large areas of sarcolemma in a single 
plane of focus showed distinct domains enriched in both 
spectrin and dystrophin, not only over I bands but also above 
M  lines and in fine longitudinal strands. Controls showed 
that the labeling was intraceUular,  was associated with the 
membrane, and was not due to processing artifacts. These 
domains are related to costameres, as the costameric pro- 
tein, vinculin, codistributed with both dystrophin and spec- 
trin.  In  muscles  from the mdx mouse  and patients  with 
DMD, which lack dystrophin, a sub-sarcolemmal lattice of 
spectrin resembling that in control muscles was present, sug- 
gesting that dystrophin is not required for the lattice to form. 
Materials and Methods 
Antibodies 
Sheep antibodies to a fusion protein containing the amino terminal 60-kD 
fragment of mouse dystrophin (Hoffman et al.,  1987) were obtained from 
Dr. L. Kunkel (Harvard Medical School, Boston, MA) and Dr. E. Hoffman 
(University of Pittsburgh, Pittsburgh, PA). A mouse mAb, 1808, to Torpedo 
dystrophin (Sealock et al.,  1991),  was from Dr. S. Froehner (Dartmouth 
Medical  School,  Hanover,  NH).  Rabbit  polyclonal antibody to  human 
fibronectin, AB1940,  and mouse mAb against human vinculin, mAb1637, 
which recognizes vinculin and metavinculin, were obtained from Chemicon 
(Temecula, CA). Rabbit antibody to vinculin has been described previously 
(Shear and Bloch,  1985). 
The peptide, Gly-Lys-Lys-Asp-Lys-Glu-Lys-Arg-Phe-Ser-Phe-Phe-Pro- 
Lys-Lys-Lys, representing the carboxy terminal sequence of the major mus- 
cle isoform of/~-spectrin (Winkelmann et al.,  1990b),  was synthesized 
(model 430A;  Applied Biosystems, Foster City,  CA) with Cys-Gly-Gly 
added to the amino terminus and purified by high performance liquid chro- 
matography on a C-18 reverse phase column (~dac, Hesperia, CA) at the 
Biopolymer Laboratory of the Department of Microbiology and Immunol- 
ogy at the University of Maryland School of Medicine (Baltimore, MD). 
It was coupled (Gentry et al., 1983) to BSA, and 200 ttg of the conjugate 
was injected subcutaneously into rabbits in complete Freund's adjuvant. 
Rabbits were boosted 1 mo later, and every 2 wk thereafter, with 50 #g of 
the peptide-BSA conjugate in incomplete adjuvant. Rabbits were bled every 
week after the first boost. Irnmunoglobulins were purified from serum by 
precipitation in 50% ammonium sulfate, followed by dialysis against PBS. 
The crude irnmunoglobulin fraction was applied to a column of Afflgel  15 
(Bio-Rad Laboratories, Richmond, CA) coupled to BSA, and the effluent 
was then applied to a column of Afiigel 15 coupled directly to the peptide, 
following the manufacturer's instructions. Bound antibody was eluted with 
0.1 M glycine-HCl, 0.5 M NaCI, pH 2.7, immediately neutralized, and dia- 
lyzed against PBS plus  10  mM  sodium azide.  Aliquots were  stored at 
-70~ 
lmmunoblotting 
Rat hindlimb muscle was suspended in a solution containing 1% deoxycho- 
late, 1% NP-40, 10 mM sodium phosphate, pH 6.8, 0.5 M NaC1, and 2 mM 
EDTA (Hoffman et al., 1989),  supplemented with protease inhibitors (0.22 
U/mi aprotinin, 1 mM benzamidine, 10 #g/ml leupeptin, 10 #g/ml antipain, 
200 #g/mi soybean trypsin inhibitor) and 10 mM sodium azide but contain- 
ing no SDS. Tissue was homogenized in a Virtis Hi-Speed "45" Homog- 
enizer (Gardiner, NY) at 4~  for a total of 2 min and incubated for 1 h at 
4~  Insoluble material was removed by centrifugation (16,000  rpm,  1 h, 
4~  SS-34 rotor; Sorvall Instruments, Newton, CT), and the supernatant 
was stored at  -50~ 
Proteins (50-60/~g/5-mm lane),  separated on 5-15 % acrylamide gra- 
dient minigels (Hoefer Scientific, San Francisco,  CA)  according to the 
method of Laemmli (1970),  were transferred electrophoretically to nitrocel- 
lulose overnight at 200 mA (Burnette, 1981). Molecular weight standards, 
obtained from Bethesda Research Laboratories (Bethesda, MD) and sup- 
plemented with purified erythrocyte spectrin (Gratzer, 1982),  were stained 
with amido black after transfer. Strips of nitrocellulose were stored in dis- 
tilled water and, before incubation with antibodies, were incubated in 3 % 
milk solids (Carnation Products, Los Angeles, CA) in PBS supplemented 
with 10 mM sodium azide and 0.5% Tween-20. Samples were labeled over- 
night with the antibody diluted in the same solution without milk solids. 
Strips were then incubated for 4 h with appropriate secondary antibody con- 
jugated to alkaline phosphatase, and bound antibodies were visualized using 
a  detection  system obtained  from  Kirkegaard  and  Perry  Laboratories 
(Gaithersburg, MD). 
Immunofluorescence 
Animals were perfused through the left ventricle with PBS.  Rat sterno- 
mastoid or mouse hamstring muscle was dissected, pinned or clamped at 
resting length, and fixed for 10 rain in 2% paraformaldehyde in PBS. In a 
few experiments, we perfused rats with 2 % paraformaldehyde in PBS, re- 
moved the sternomastoid muscle, and fixed it for 30 min longer. Tissue was 
blotted dry and plunged into a slush of liquid N2. DMD and normal human 
muscle samples were obtained from patients undergoing routine diagnostic 
muscle biopsies and frozen in liquid N2-cooled isopentane. Sections 4-/~m 
thick were cut on a cryostat (model 2800,  Frigocut; Reichert-Jung, Cam- 
bridge Instruments, Deerfield, IL), deposited on slides coated with 0.5% 
gelatin, 0.05 % chromium potassium sulfate, and stored at -500C. Bundles 
of rabbit psoas muscle were tied to wooden sticks in situ, dissected, and 
stored in glycerol at 4~  Samples were teased to single fibers in glycerol, 
and were washed extensivel3/with PBS. 
Sections or fibers were incubated for 15 vain in PBS containing 1 mg/mi 
BSA and 10 mM sodium azide (PBS/BSA), to block non-specific binding 
of antibody, and stained for 1 h with primary antibody diluted in the same 
solution. Samples were washed, blocked again for 15 min in PBS/BSA, and 
labeled for 1 h with combinations of the following secondary antibodies: 
10 #g/ml for fluoresceinated donkey anti-rabbit IgG, goat anti-rabbit IgG, 
or rabbit anti-mouse IgG; 1 tzg/ml for biotinylated goat anti-mouse IgG or 
donkey anti-sheep IgG.  Samples were then labeled for 1 h with 4  #g/mi 
rhodamine streptavidin. All incubations were performed at room tempera- 
ture in a humidified chamber. 
In some experiments, we labeled muscles with the lipid probe, 3,3'- 
di(Cl2H25) indocarbocyanine iodide (Cl2-dil; Wolf,  1988).  Muscles fixed 
after dissection were labeled en bloc with 1 #g/ml Ct2-diI for 10-30 min, 
rinsed in PBS, and frozen and sectioned as described above. Such samples 
were then labeled as above with anti-spectrin antibody.  C12-diI was visual- 
ized under rhodamine optics. 
Samples were mounted in nine parts glycerol, one part 1 M Tris-HCI, 
pH  8,  supplemented with  1 mg/ml p-phenylenediamine to reduce pho- 
tobleaching (Johnson et ai., 1982).  Conventional immunofluorescence ob- 
servations were performed on an IM-35  microscope (Carl Zeiss, Ober- 
kochen, Germany) with a 63X/N.A. 1.4 phase objective (Leitz, Rockleigh, 
NJ).  Photographs were taken on TMAX  P3200  film (Eastman Kodak, 
Rochester, NY) and were processed  to an ASA of 1,600. Some samples were 
observed with a Bio-Rad MRC 600 confocal scanning laser microscope 
(Bio-Rad Laboratories) at a Z axis resolution of  0.56/zm, obtained with the 
same objective. Images were sharpened and saved using SOM 4.61 software 
(Bio-Rad Microsciences Division). NIH Image 1.41 software was used to 
increase the contrast of the images and to generate graphs of the fluores- 
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the Montage FRI  machine (Presentation Technologies, Sunnyvale, CA). 
Statistics 
A correlation coefficient of the values used to plot the image intensities in 
Fig. 3, e and fwas obtained using StatView SE +  Graphics (Abacus Con- 
cepts, Inc., Berkeley, CA). A regression plot of this line was generated for 
Fig. 3 g. The slope of this line was shown to be significantly different from 
zero in a two-tailed t test using the formula: t  =  r(N  -  2)~a/(l  -  r2) ~a 
(BoRon,  1984). 
Materials 
Rats were from Zivic Miller (Zelienople, PA), rabbits were from Hazelton 
Research Products (Denver, PA), and mice were from Jackson Laboratories 
(Bar Harbor, ME).  C12-diI  was generously provided by Dr. A. Waggoner 
(Carnegie-Mellon  University,  Pittsburgh,  PA).  Conjugates of antibodies 
and streptavidin were obtained from Jackson Immuno Research Laborato- 
ries (West Grove, PA). All other chemicals, except where noted, were from 
Sigma Chemical  Co.  (St.  Louis,  MO). 
Results 
Antibodies 
Sheep antibodies to mouse dystrophin (Hoffman et al., 1987) 
and a mouse mAb,  1808, to Torpedo dystrophin (Sealock et 
al.,  1991) specifically recognized a doublet at ~400 kD in 
immunoblots of normal rat skeletal muscle but not of mdx 
mouse muscle (Fig.  1), as previously reported (Hoffman et 
al., 1987, 1988; Byers et al., 1991; Sealocket al., 1991). An- 
tibodies to the major muscle isoform of ~-spectrin recog- 
nized a doublet with an apparent molecular weight of ,,o 270 
kD, as predicted (Winkelmann et al., 1990b), in both normal 
and mdx muscle (Fig.  1).  The spectrin doublet labeled in 
homogenates of mdx mouse muscle was more apparent in 
5 % polyacrylamide gels (not shown).  The presence of two 
spectrin bands could be due to NH2-terminal proteolysis of 
/~-spectrin or to the existence of two isoforms of the protein, 
perhaps the result of alternative splicing (e.g., Winkelmann 
et al.,  1990b). Both bands of the doublet are distinct from 
erythrocyte  B-spectrin, which has a molecular weight of 246 
kD (Winkelmann et al.,  1990a). 
Both monoclonal and polyclonal anti-vinculin antibodies 
recognized two proteins in immunoblots of rat skeletal mus- 
cle (Fig.  1). The apparent molecular masses of these bands, 
116 and  133 kD, are consistent with those of vinculin and 
metavinculin (Coutu and Craig, 1988; Gimona et al., 1988b; 
Weller et al.,  1990).  An additional mAb against vinculin 
reacted with the same bands but failed to label sections by 
immunofluorescence (not shown).  Although high levels of 
metavinculin have not been found in adult skeletal muscle 
before, previous reports indicate that the level of expression 
of metavinculin varies widely among different striated mus- 
cles in different species (Feramisco et al., 1982; Saga et al., 
1985; Glukhova et al., 1986; Belkin et al., 1988a,b; Gimona 
et al., 1988a). In fact, the rabbit anti-vinculin antibody used 
here only recognized a single vinculin band in chicken skele- 
tal muscle (Shear and Bloch,  1985). 
Normal Muscle 
Cytoskeletal Proteins in a Subsarcolemmal Lattice. We la- 
beled  teased  rabbit  muscle  fibers  and  longitudinal  cryo- 
Figure L Specificity of antibodies to dystrophin; spectrin, and vin- 
culin. Homogenates of normal rat (a) and mdx mouse (b) muscle 
were separated by SDS-PAGE and transferred to nitrocellulose. 
Strips of nitrocellulose were labeled with antibody and visualized 
with  secondary  antibodies  conjugated  to  alkaline  phosphatase. 
Control antibodies were mope 21 mouse monoclonal IgG (a, lane 
1, b, lane 1), normal sheep serum (a, lane 3), and normal rabbit 
serum (a, lane 5, b, lane 3). Anti-dystrophin antibodies, mab 1808 
(a, lane 2, b, lane 2) and sheep anti-dystrophin fusion protein (a, 
lane 4), label a doublet at ,'0400 kD in normal rat but not mdx 
mouse muscle. Rabbit antibody against the major muscle isoform 
of B-spectrin labels a doublet at '~270 kD in both normal rat, (a, 
lane 6) and mdx mouse (b, lane 4) muscle. Both mouse (a, lane 
7) and rabbit (a, lane 8) anti-vinculin antibodies labeled two bands 
of 116 and 133 kD in normal rat muscle. Molecular weight stan- 
dards (Mr x  10  3) are indicated on the left. Arrows on the right in- 
dicate (in descending order) dystrophin,  spectrin,  metavinculin, 
and vinculin. Labeling of the lower molecular weight bands in a 
lanes 2 and 4, and b, lane 2 can be accounted for by non-specific 
interactions, as shown for pre-immune or irrelevant antibodies (a, 
lane 1, a, lane 3, b, lane 1 ). Immunofluorescence labeling is there- 
fore likely to be specific. 
sections of  rat, mouse, and human skeletal muscle with these 
antibodies by indirect immunofluorescence. As previously 
reported, both anti-dystrophin antibodies stained only the 
sarcolemma of myofibers (Hoffman et al.,  1987; Sealock et 
al., 1991). We occasionally saw a regularly spaced, punctate 
pattern  at  the  periphery  of many  fibers,  however.  Anti- 
dystrophin antibodies labeled the membrane adjacent to the 
M  lines and the I bands, but often did not label at Z  lines 
(Fig. 2, b and c). The source of the repetitive pattern became 
apparent in  fibers which had  been  sectioned tangentially 
such that large areas of membrane were present in a single 
plane of focus. These "glancing sections" showed a lattice- 
like pattern of label (Fig.  2 e), with no cytoplasmic back- 
ground, suggesting a sarcolemmal location (see below). This 
lattice consisted of occasional longitudinal strands and peri- 
odic transverse structures. The transverse structures were of 
two types: one over I bands appeared as a pair of  thicker lines 
separated by a barely discernible unstained space overlying 
the Z  lines and the second appeared as thin lines overlying 
most of the M lines. The longitudinal strands and those ele- 
ments  above the  I  bands  resemble a  sub-membrane,  two 
dimensional lattice of cytoskeletal proteins described previ- 
ously in cardiac and skeletal muscle (see Discussion). Pardo 
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/3-spectrin are  present  in  a 
sub-sarcolemmal lattice in rat 
and  rabbit  skeletal  muscle. 
Longitudinal  sections  (4-t~m 
thick) of  rat sternomastoid (a- 
f) and individual fibers of rab- 
bit psoas  (g-i)  muscle were 
colabeled  with  rabbit  anti- 
fl-spectrin (a, d,  and g) and 
mAb 1808 anti-dystrophin (b, 
e, and h) followed by tluores- 
ceinated or biotinylated anti- 
antibodies  and  rhodamine 
streptavidin. The correspond- 
ing phase micrographs  (c, f, 
and  i)  are  present  to  facili- 
tate comparison to contractile 
structures.  In  a  section per- 
pendicular to the sarcolemma 
(a-c),  spectrin (a),  and dys- 
trophin  (b)  are  labeled  on 
the sarcolemma in a punctate 
pattern  corresponding to the 
adjacent I bands (single white 
arrowheads)  and  M  lines 
(double  white  arrowheads). 
Note the discontinuity in the 
center of the I band staining 
which corresponds to the ad- 
jacent  Z  line  (black  arrow- 
heads). In sections tangential to the sarcolemma of a myofiber, a lattice of spectrin (d) and dystrophin (e) has elements above the I bands 
and M lines and occasional longitudinal strands (white arrows). Again note the discontinuity of the I band staining above the Z line. Arrow- 
heads label structures as in a-c.  The lattice of spectrin (g) and dystrophin (h) seen in permeabilized rabbit psoas muscle is similar to 
that seen in d-f. Because of the curvature of the fiber, only part of the surface is in focus. Bars: (a-c), 5 #m; (d-f), 10 #m; (g-i), 5 #m. 
and co-workers named the elements overlying the I bands 
"costameres" (Pardo et al., 1983a). The longitudinal strands 
have no obvious correlate in the contractile apparatus.  We 
cannot rule  out the  possibility  that  the  labeling  of these 
strands is due to folds in the sarcolemma. 
Longitudinal sections of rat skeletal muscle stained with 
antibodies to the major muscle isoform of/3-spectrin also re- 
vealed a punctate pattern at the edges of myofibers and a lat- 
tice in glancing sections (Fig.  2,  a  and d).  In double im- 
munofluorescence  labeling, dystrophin and the major muscle 
isoform of/3-spectrin colocalized to these structures (Fig. 2, 
a-f). Similar colabeling of a membrane lattice was obtained 
in intact, permeabilized fibers from the rabbit psoas muscle 
(Fig.  2, g-i).  Antibodies did not stain a  lattice unless the 
fibers were first permeabilized with detergent (not shown), 
consistent with the idea that the lattice resides on the inner 
surface of the sarcolemma. Thus, at the level of resolution 
afforded by fluorescence microscopy, dystrophin and spec- 
trin colocalize on the cytoplasmic side of the sarcolemma in 
a  lattice with  major  components over the  M  lines  and  I 
bands. 
We  performed  additional  experiments  to  examine  the 
specificity of antibody labeling. Sections stained with non- 
immune IgG (mopc21), or pre-immune rabbit IgG or sheep 
serum, followed by secondary and tertiary reagents, showed 
minimal background label. Labeling by the primary, second- 
ary, or tertiary reagents alone also gave no staining. Finally, 
sections labeled with a single primary antibody followed by 
combinations of secondary and tertiary reagents appropriate 
for double labeling showed that there was no species cross- 
reactivity of the secondary and tertiary reagents. Thus the 
patterns of labeling described above were not due to non- 
specific labeling by primary antibodies,  to  species cross- 
reactivity of secondary antibodies, or to "bleed through" of 
rhodamine and fluorescein. The labeling shown in Figs. 2-5 
is therefore specific. 
As previous reports have localized vinculin to costameres 
and longitudinal strands (Craig and Pardo,  1983; Pardo et 
al., 1983a,b; Shear and Bloch, 1985; Terracio et al., 1990), 
we compared the distribution of dystrophin to that of vincu- 
lin. In longitudinal sections of rat skeletal muscle, antibodies 
to vinculin and dystrophin colabeled the three domains of 
the sub-sarcolemmal lattice (Fig. 3, a-d). Both proteins are 
enriched above I bands and M  lines, with the area labeled 
above the I bands appearing wider than that above the M 
lines. In addition, a small split in the labeling above I bands 
is evident. Labeling for these proteins was further compared 
by  confocal  scanning  laser  microscopy  (Fig.  3,  c-g).  A 
limited area of  membrane with lattice labeled for both vincu- 
lin and dystrophin was digitized (Fig. 3, c and d) and scanned 
to obtain graphs of label intensity (Fig.  3,  e  and f).  The 
graphs  revealed almost  identical  patterns  of label  as  de- 
scribed above, e.g., labeling over the M  lines and I bands 
with a decrease at the center of the I bands above the Z lines. 
An analysis of correlation between the two plots (Fig. 3 g) 
yielded a correlation coefficient  (r) of 0.885. The slope of  the 
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utes  with  dystrophin  in  the 
subsarcolemmal lattice. Glanc- 
ing sections  of rat stemomas- 
told muscle were labeled  by 
fluorescein  and  rhodamine 
fluorescence for dystrophin (a 
and c) and vinculin (b and d). 
For a-d,  arrows  and  arrow- 
heads denote the same struc- 
tures as in Fig. 2. Dystrophin 
(a and c) distributes  with vin- 
culin (b and d) at the sareo- 
lemma  above  the  I  bands, 
above  the  M  lines,  and  in 
longitudinal  strands,  a  and b 
were collected by convention- 
al immunofluorescence,  while 
c  and d  were collected on a 
Bio-Rad  confocal  scanning 
laser microscope  and analyzed 
with  NIH  Image  1.41 soft- 
ware.  The  areas  outlined  c 
and d  (20  ￿  65 pixels)  were 
scanned for labeling intensity, and the average of  each vertical column of  20 pixels was plotted. The results show that labeling for dystrophin 
(e) and vinculin (f) is present above the M lines  (black arrows) and I bands (w/de outlined arrows). The labeling  above the I bands is 
both wider than that above the M lines and is decreased in the center above the Z lines (small black arrowheads), g shows an analysis 
of the lines plotted in e andffor correlation with Statview  SE +  Graphics which yielded a correlation coefficient (r) of 0.885. The slope 
of the line,  0.644, was significantly  different  from zero (P <  0.001). The values on the ordinate and abscissa  indicate  the pixel intensity 
on a gray scale of 0 to 255.  Bars: (a and b),  10 #m; (c and d), 2.2 #m. 
line, 0.644,  is significantly different from zero (P <0.001). 
The lack of a  one-to-one relationship between the labeling 
by the two antibodies may be explained by differences in rela- 
tive amounts of  dystrophin and vinculin, by differences in the 
binding constants and stoichiometries of binding of both the 
primary and secondary antibodies, and by the fact that label- 
ing for dystrophin was enhanced using biotinylated second- 
ary antibody followed by rhodamine streptavidin.  From the 
plots and the correlation data, we conclude that the labeling 
for  dystrophin  and  vinculin  is  indeed  coincident  at  the 
Figure 4.  The dystrophin-spectrin lattice 
is present at intact sareolemma. Glancing 
sections of  rat sternomastoid muscle were 
colabeled  with  anti-dystrophin  (a)  and 
anti-fibronectin  (b), and with anti-spectrin 
(c) and C12-diI (d) as described in Mate- 
rials  and Methods. White arrows and all 
arrowheads denote the same structures as 
in Fig. 2. Black arrows point to the edges 
of  the lattice (a and c) and of  areas labeled 
with anti-fibronectin  (b) and Ct2-diI (d), 
where the ceil surface exits the plane of 
section. Results suggest that the lattice of 
dystrophin and spectfin is present in areas 
of  the  sareolemma  that  are  intact,  as 
judged by continuous labeling  by Cl2-diI 
and ami-fibronectin,  Bars,  5 #m. 
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dystrophin  but  display  a  lattice of 
/~-spectrin. Glancing sections from nor- 
mal  mouse hamstring (a  and  b)  and 
human quadriceps (e and  f) muscles  dis- 
play a lattice of spectrin (a and e) and 
dystrophin (b and  f) similar to that seen 
in normal rat and rabbit muscle (Fig. 2). 
Glancing sections from mdx mouse (c 
and d) and DMD human (g and h) mus- 
cles show a lattice of spectrin (c and g) 
but  contain no dystrophin (d and h). 
All samples were colabeled with anti- 
dystrophin  and  anti-spectrin.  Arrows 
and arrowheads are as described in Fig. 
2. Bars, 5 ~m. 
highest levels of resolution afforded by optical techniques. 
Therefore, like antibodies to spectrin and dystrophin, anti- 
bodies to vinculin label the sarcolemma not only at costa- 
meres and in longitudinal strands,  as previously reported 
(Craig and Pardo,  1983;  Pardo et al.,  1983a,b;  Shear and 
Bloch, 1985; Terracio et al., 1990),  but also above M lines. 
As the anti-vinculin antibodies used in this study also label 
metavinculin (Fig. 1), we cannot rule out the possibility that 
vinculin and metavinculin distribute to different domains of 
the lattice. 
The Subsarcolemmal Lattice Is Not Created Ara'factu- 
ally.  The  lattice  was  further  compared  to  labeling  for 
fibronectin and  for  the  lipid  bilayer of the  sarcolemma. 
Labeling by antibodies to fibronectin appeared as an almost 
uniform sheath over the surface of the muscle fiber, as ex- 
pected (Sanes,  1982).  The lattice of dystrophin was visible 
at the same focal plane (Fig. 4, a and b). Neither fibronectin 
nor dystrophin were seen in areas where the plane of section 
went deeper into the sarcoplasm or into the extracellular 
space (denoted by black arrows in Fig. 4, a and b), suggest- 
ing that both were present close to the sarcolemma. Labeling 
of intact fibers with the indocarbocyanine lipid probe, C~:- 
diI (Wolf,  1988),  followed by sectioning and labeling with 
anti-spectrin antibodies, showed the sub-sarcolemmal lattice 
in the same regions that stained almost uniformly with C~:- 
diI (Fig. 4, c and d). As with fibronectin, labeling with Ct2- 
diI extended only as far as that for spectrin and not deeper 
into the sarcoplasm (Fig. 4,  c  and d).  The slight lack of 
uniformity in the C12-diI label was probably due to penetra- 
tion of small amounts of C~2-diI from the sarcolemma into 
the T-tubules. The lattice also remained intact in sections 
from muscle which had been extensively fixed by perfusion 
followed by fixation en bloc (not shown). Since the lattice re- 
mained intact where C12-diI and anti-fibronectin antibodies 
labeled  the  membrane  almost  uniformly and  in  muscle 
which had been extensively fixed, it is unlikely that process- 
ing of the sample was accompanied by fragmentation or re- 
organization of the membrane or membrane-associated pro- 
teins. 
Dystrophic Muscle 
Muscles from the mdx mouse and from patients with DMD 
were colabeled with antibodies to dystrophin and spectrin. 
Glancing  sections  of normal  mouse and  human  muscles 
showed a lattice similar to that seen in rat muscle (Fig. 5, 
a, b, e, and  f). Glancing sections from mdx and DMD mus- 
cle contained no dystrophin, as expected (Fig. 5, d and h). 
They did, however, contain a spectrin-rich sub-sarcolemmal 
lattice of transverse elements overlying the I bands and M 
lines and containing occasional longitudinal strands (Fig. 5, 
c and g). The lattices in dystrophic muscle always appeared 
less ordered than in controls, perhaps due to the presence of 
regenerating fibers commonly seen in these muscles (Car- 
penter and Karpati,  1979;  Torres and Duchen,  1987). 
Discussion 
This  report  is  the  first  to  show  that  dystrophin  is  not 
homogeneously distributed under the sarcolemma of ver- 
tebrate skeletal muscle but is instead concentrated at discrete 
sites. The absence of periodicity reported for immunolabel- 
ing with anti-dystrophin and secondary antibody conjugated 
to HRP (Carpenter et al., 1990) was probably due to diffuse 
deposition of enzyme reaction product on nearby structures, 
a phenomenon noted previously (Sanes, 1982). Electron mi- 
croscopic studies of muscle labeled with immunogold (Wat- 
kins et al.,  1988;  Cullen et al.,  1990;  Byers et al.,  1991; 
Wakayama and Shibuya,  1991) afforded labeling so sparse 
that the pattern we describe would have been very difficult 
to detect. In addition, those studies did not attempt to corre- 
late immunogold labeling on the sarcolemma to the underly- 
ing contractile apparatus.  Even immunofiuorescence may 
not detect the periodic distribution of  dystrophin if longitudi- 
nal sections are too thick or if  the sarcolemma is skewed such 
that distinct label at I bands and M lines cannot be observed. 
Limited regions of periodic labeling are apparent in some 
reports  (Bonilla et al.,  1988b;  Ohlendieck et  al.,  1991), 
however. 
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at the sarcolemma might be a  result of disruption of the 
membrane during processing. We tested this possibility in 
three experiments. Sections from extensively fixed myofibers 
had the same labeling patterns as those used in most of our 
studies, which were lightly fixed. This suggests that these 
patterns were not caused by inadequate fixation of the tissue. 
In addition, sections showed smooth labeling of the extracel- 
lular matrix by anti-fibronectin antibodies, and of the lipid 
bilayer by C~2-DiI, in the same focal plane as the periodic 
lattice of  dystrophin and spectrin. Because there was no frag- 
mentation of either  the  extracellular matrix  or  the  lipid 
bilayer, it is unlikely that the cytoskeletal proteins under- 
neath the sarcolemma were disrupted. Therefore, the label- 
ing of dystrophin, spectrin, and vinculin that we report is 
probably not the result of processing artifact. 
These results suggest that dystrophin and the major muscle 
isoform of/~-spectrin are present in the structures which con- 
nect the contractile apparatus to the sarcolemma and stabi- 
lize the sarcolemma itself (see below). Dystrophin is similar 
in primary structure to spectrin, a major component of the 
erythrocyte sub-membrane network and has been shown to 
be present in a spectrin-rich filamentous network in acetyl- 
choline receptor clusters of cultured myotubes (Dmytrenko 
et al., manuscript submitted for publication). A similar net- 
work is present under the  sarcolemma of mouse skeletal 
muscle (Wakayama and Shibuya, 1990,  1991). We think it 
likely that dystrophin and fl-spectrin are part of such a net- 
work in the membrane domains described in this report. 
Ultrastructural experiments have shown that connections 
between the contractile apparatus and electron-dense areas 
on the sarcolemma occur at the M and Z lines in some stri- 
ated muscles. Some filaments course directly from M lines 
to the membrane while other filaments travel from Z lines 
to the sarcolemma underlying the I bands in rat diaphragm 
and frog semitendinosis (Pierobon-Bormioli,  1981; Street, 
1983).  In bee flight, mammalian cardiac, and chicken tonic 
skeletal myofibers, however,  attachments occur only at Z 
lines (Garamv6gyi,  1965;  Chiesi et al.,  1981; Shear and 
Bloch, 1985).  These connections allow for the transmission 
of force laterally along the myofiber to the extracellular ma- 
trix, to adjacent myofibers, and, ultimately, to the tendon 
(Street, 1983). In addition, these structures may stabilize the 
sarcolemma in two ways:  (a) They may support the mem- 
brane in the areas where the most stress is applied-the sites 
of attachment between the sarcolemma and the contractile 
apparatus.  The  sub-membrane  skeleton  that  is  probably 
found at these sites would stabilize the membrane. It could 
also connect the contractile apparatus to extracellular struc- 
tures through integral membrane proteins such as integrins, 
which may be enriched over I bands (Terracio et al., 1989, 
1990), or through the glycoprotein complex associated with 
dystrophin (Campbell and Kahl, 1989; Ervasti et al., 1990; 
Yoshida et al., 1990; Ohlendieck et al., 1991), a component 
of which  binds  laminin  (Ibraghimov-Beskrovnaya et  al., 
1992).  As  the  disruption  of the  membrane  skeleton  of 
erythrocytes through mutations of the component proteins 
causes  hereditary  spherocytosis  and  elliptocytosis  (Gal- 
lagher et al.,  1990;  Liu et al.,  1990;  Palek and Lambert, 
1990),  a similar disruption of a sub-sarcolemmal network 
could cause damage such as is seen in muscle from patients 
with DMD.  (b)  The connections between the sarcolemma 
and contractile apparatus also stabilize the sarcolemma dur- 
ing contraction by creating an ordered "festooning" of the 
membrane in which the non-attached membrane bulges into 
the extracellular space to maintain cell volume (Pierobon- 
Bormioli, 1981; Pardo et al., 1983a; Street, 1983; Shear and 
Bloch,  1985).  Without some type of ordered anchorage of 
the membrane, the sarcolemma would fold in a disordered 
fashion and so might be damaged during contraction. 
The absence of dystrophin from the sub-sarcolemmal lat- 
tice  may account  in  part  for the  damage that occurs  in 
Duchenne's muscular dystrophy. The primary site of damage 
in dystrophic muscle is the sarcolemma (Mokri and Engel, 
1975;  Carpenter and Karpati,  1979).  The relative impor- 
tance of dystrophin and fl-spectrin in maintaining the in- 
tegrity of the sarcolemma and the contractile apparatus has 
not been determined. Although a lattice of spectrin is present 
in dystrophic muscle, the lack of dystrophin may render it 
too weak to withstand the stress of normal contraction. Mus- 
cles from both mdx mice and patients with DMD lack dystro- 
phin (Hoffman et al., 1987), but contain a lattice of spectrin, 
yet mdx muscle sustains less damage despite some structural 
modifications (Bulfield et al.,  1984;  Tortes and Duchen, 
1987; Tidball and Law, 1991). The lattice of spectrin may 
therefore be sufficient to protect mdx muscle. The amount of 
damage to myofibers seems to correlate to the amount of 
stress on the muscle (Florence et al., 1985; Webster et al., 
1988),  and myofibers in mice probably undergo less stress 
than human myofibers because of the smaller body mass of 
mice. The higher stress to which human muscle is exposed 
may render a lattice containing spectrin but not dystrophin 
inadequate to protect DMD muscle from irreversible dam- 
age and clinical manifestations. 
In  immunofluorescence studies  of striated  muscle,  fl~ 
integrin, a collagen receptor, -y-actin, spectrin, ankyrin, vin- 
culin, talin, and intermediate filament proteins have been 
shown to localize to a sub-membrane, two-dimensional lat- 
tice containing longitudinal strands and elements overlying 
the I bands (Repasky et al.,  1982;  Craig and Pardo,  1983; 
Nelson and Lazarides, 1983; Pardo et al., 1983a,b; Nelson 
and Lazarides,  1984;  Shear and Bloch,  1985;  Terracio et 
al.,  1989, 1990).  In addition, spectrin and ankyrin at the 
sarcolemma have been localized above M  lines as well as 
the two-dimensional lattice of costameres and longitudinal 
strands (Repasky et al., 1982; Craig and Pardo, 1983; Nel- 
son and Lazarides, 1983, 1984). The results presented above 
show that these three domains contain dystrophin and the 
major muscle isoform of  fl-spectrin. We have also shown that 
vinculin or metavinculin is present over M lines as well as 
over I bands and in longitudinal strands. Vinculin has only 
been reported under the skeletal muscle sarcolemma at the 
latter two structures by other investigators (Craig and Pardo, 
1983; Pardo et al., 1983a).  As we do not yet have antibodies 
that specifically recognize either vinculin or metavinculin, 
we cannot rule out the possibility that metavinculin is selec- 
tively enriched at the domains overlying the M  lines. The 
failure to detect vinculin over M lines in earlier studies of 
chicken muscle (Craig and Pardo, 1983; Pardo et al., 1983a; 
Shear and Bloch, 1985) may be explained by differences in 
expression of vinculin and metavinculin among fiber types 
or species (Feramisco et al., 1982; Saga et al., 1985; Gluk- 
hova et al.,  1986;  Belkin et al.,  1988a,b;  Gimona et al., 
1988a). 
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may have to be expanded from structures at or flanking Z 
lines to include all structures that mediate lateral attachment 
of the contractile apparatus to the sarcolemma. If that is the 
case, then, like vinculin, other proteins previously found in 
costameres and in longitudinal strands may be present above 
M  lines.  We are currently investigating the distribution of 
such proteins at the sarcolemma  to determine if they are 
limited to positions above the I bands or if they are more 
widespread. 
We thank Drs. S. Froehner, E. Hoffman, and L. Kunkel for their generous 
gifts of antibodies to dystrophin, and Dr. A. Waggoner for his gift of Cl2- 
diI. We are also grateful to Dr. J. S. Morrow for his collaboration at the 
early stages of this work and to Dr. R. Sealock for useful discussion. We 
also thank the reviewers for their comments. 
This research has been supported by grants from the National Institutes 
of Health to Dr. W inkelmarm (HL39834) and to Dr. Bloch (NS  17282) and 
from the Muscular Dystrophy Association to Dr. Bloch. Mr. Porter has 
been supported by a predoctoral training grant (GM08181) from the Na- 
tional Institutes of Health. Dr. Dmytrenko is the recipient of a Clinical In- 
vestigator Development Award (NS01255). 
Received for publication 5 December 1991 and in revised form 11 March 
1992. 
References 
Appleyard, S. T., M. J. Duma, V. Dubowitz, M. L. Scott, S. J. Pittman, and 
D. M. Shotton.  1984. Monoclonal  antibodies  detect a spectrin-like  protein 
in normal and dystrophic human  skeletal  muscle.  Proc.  Natl.  Acad.  Sci. 
USA.  81:776-780. 
Arahata,  K., S. Ishiura, T. Ishiguro,  T. Tsukahara,  Y. Suhara,  C. Eguchi, T. 
Ishihara,  I.  Nonaka,  E.  Ozawa,  and  H.  Sugita.  1988. Immunostaining 
of skeletal  and  cardiac  muscle  surface  membrane with antibody  against 
Duchenne muscular dystrophy peptide. Nature (Lord.).  333:861-863. 
Beam, K. G. 1988. Duchenne muscular dystrophy: localizing the gene product. 
Nature (Lord.).  333:798-799. 
Beikin, A. M., O. I. Ornatsky, M. A. Glukhova, and V. E. Koteiiansky.  1988a. 
Immunolocalization of meta-vinculin in human smooth and cardiac muscles. 
J.  Cell Biol.  107:545-553. 
Belkin, A. M., O. I. Ornatsky,  A. E. Kabakov,  M. A. Glukhova,  and V. E. 
Koteliansky.  1988/7. Diversity of vinculin/meta-vinculin in human tissues 
and cultivated cells. J.  Biol.  Chem.  263:6631-6635. 
Bennett, V. 1990. Spectrin-based membrane skeleton: a multipotential adaptor 
between plasma membrane and cytoplasm. Physiol.  Rev. 70:1029-1065. 
Bloch, R. J., and J. S. Morrow. 1989. An unusual B-spectrin associated with 
clustered acetylcholine  receptors. J.  Cell Biol.  108:481-493. 
Bolton,  S. 1984. Pharmaceutical  statistics.  Marcel Dekker, Inc., New York, 
NY. 207. 
Bonilla, E., C. E. Samitt, A. F. Miranda, A. P. Hays, G. Salviati, S. DiManro, 
L. M. Kunkel, E. P. Hoffman, and L. P. Rowland. 1988a. Duchenne muscu- 
lar dystrophy:  deficiency of dystrophin at the muscle cell surface.  Cell. 54: 
447-452. 
Bonilla, E., B. Schnfidt, C. E. Samitt, A. F. Miranda, A. P. Hays,  A. B. S. 
De Oliveira,  H. W. Chang,  S. Servidei,  E. Ricci, D. S. Younger, and S. 
DiMaurn.  1988b. Normal and dystrophin-deficient  muscle fibers in carriers 
of the genr for duchenne muscular dystrophy. Am. J. Pathol.  133:440-445. 
Bulfield, O., W. G. Siller, P. A. L. Wight, and K. J. Moore. 1984. X chromo- 
some-linked  muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. 
USA. 81:1189-1192. 
Burnette, W. N. 1981. "Western blotting": electrophoretic  transfer of proteins 
from sodium dodecyl sulfate~polyacrylamide gels to unmodified nitrocellu- 
lose and radiographic detection with antibody and radioiodinated protein A. 
Anat.  Biochem.  112:195-203. 
Byers, T. J., L. M. Kunkel, and S. C. Watkins. 1991. The subcellular distribu- 
tion of dystrophin in mouse skeletal,  cardiac,  and smooth muscle.  J.  Cell 
Biol.  115:411-421. 
Campbell, K. P., and S, D. Kahl.  1989. Association of dystrophin and an inte- 
gral membrane glycoprotein.  Nature (Lord.).  338:259-262. 
Carpenter, S., and G. Karpati.  1979.  Duchenne muscular dystrophy:  plasma 
membrane loss initiates  muscle cell necrosis unless it is repaired. Brain. 
102:147-161. 
C~ter,  S., G. Karpati, E. Zubrzycka-Gaarn,  D. E. Bulman, P. N. Ray, and 
R. (3. Worton. 1990. Dy~-ophin is localized  to the plasma membrane of  hu- 
man skeletal  muscle fibers by electron-microscopic cytocbemical  study. 
Muscle and Nerve.  13:376-380. 
Chang, H. W., E. Bock, and E. BoniUa. 1989. Dystrophin in electric  organ 
of  Torpedo californica  homologous  to  that  in  human muscle.  J. BioL Chem. 
264:20831-20834. 
Chiesi,  M., M. M. Ho,  G. Inesi,  A. V. Somlyo, and  A. P.  Sornlyo.  1981.  Pri- 
mary role  of sarcoplasmic  reticulum in phasic contractile  activation  of 
cardiac  myocytes with shunted myolemma. J. Cell Biol. 91:728-742. 
Coutu, M. D. and S.  W. Craig.  1988.  cDNA-derived sequence  of  chicken  em- 
bryo vinculin.  Proc. Natl. Acad. Sci. USA. 85:8535-8539. 
Craig,  S.  W., and  J.  V. Pardo. 1983. Gamma actin,  spectrin,  and  intermediate 
filament proteins  colocalize  with vinculin  at costameres, myofibril-to- 
sarcolemma attachment  sites.  Cell Motil.  3:449-462. 
CuUen,  M. J.,  J.  Walsh,  L.  V.  B.  Nicholson,  and  J.  B.  Harris.  1990.  Ultrastruc- 
rural  localization  of  dystrophin  in  human muscle  by  using  gold  immunolabel- 
ling.  Proc. R. Soc. Lond. B. 240:197-210. 
Davison, M. D., and D. R. Critchley.  1988. ot-Actinins and the DMD protein 
contain  spectrin-like  repeats.  Cell.  52:159-160. 
Ervasti, J. M., K. OMendieck, S. D. Kahl, M. G. Gaver, and K. P. Campbell. 
1990. Deficiency of a g lycopmtein component of the dystrophin complex in 
dystrophic  muscle.  Nature (Lond.).  345:315-319. 
Feramisco, J. R., J. E. Smart, K. Burridge, D. M. Helfman, and G. P. Thomas. 
1982. Co-existence  of vinculin and a vinculin-like protein of higher molecu- 
lar weight in smooth muscle. J. Biol.  Chem.  257:11024-11031. 
Florence, J. M., P. T. Fox, G. J. Planer, and M. H. Brooke.  1985. Activity, 
creatine kinase and myoglobin in I)ucherme muscular dystrophy:  a clue to 
etiology? NeuroL 35:758-761. 
Gallagher,  P. G., W. T. Tse, and B. G. Forget. 1990. Clinical and molecular 
aspects of disorders of the erythrocyte membrane skeleton. Sere. Perinatol. 
14:351-367. 
Garamv61gyi, N. 1965. Inter-Z bridges in the flight muscle of the bee. J. Ultra- 
structure Res.  13:435-443. 
Gentry, L. E., L. R. Rohrschneider, J. E. Casnellie,  and E. G. Krebs. 1983. 
Antibodies to a defined region of pp60  *r~ neutralize the tyrosine-specific ld- 
nase activity.  J. Biol.  Chem.  258:11219-11228. 
Gimona, M., J. V. Small, M. Mneremans, J. Van Damme, M. Puype, and J. 
Vandekerckhove.  1988a.  Molecular domain strncmre of porcine vincniin 
and metavinculin.  Protoplasma.  145:133-140. 
Gimona, M., J. V. Small, M. Moeremans, J. Van Damme, M. Puype, and J. 
Vandekerckhove.  1988b. Porcine vinculin and metavinculin differ by a 68- 
residue  insert located close to the carboxy-terminal  part of the molecule. 
EMBO (Eur. MoL  Biol.  Organ.)J.  7:2329-2334. 
Glukhova, M. A,, A, E. Kabakov, A. M. Belldn, M, G. Frid, O. I. Oruatsky, 
N. I. Zhidhova,  and V. E. Koteliansky.  1986. Meta-vinculin distribution in 
adult human tissues and cultured cells. FEBS (Fed. Eur. Biochem,  Soc. ) Left. 
207:139-141. 
Gratzer, W. B. 1982. Preparation of spectrin. Methods EnzymoL 85:475--480. 
Hoffman, E. P., R. H. Brown Jr., and L. M. Kunkel.  1987. Dystrophin:  the 
protein product of the Duchenne muscular dystrophy locus. Cell.  51:919- 
928. 
Hoffman, E. P., K. H. Fischbeck, R. H. Brown, M. Johnson, R. Medori, J. D. 
Loike, J. B. Harris, R. Waterston, M. Brooke,  L. Specht, W. Kupsky, J. 
Chamberlain,  C. T. Caskey, F. Shapiro,  and L  M. Kunkel.  1988. Charac- 
terization  of dystrophin in  muscle-biopsy  specimens  from patients  with 
Duchenne's or Becket's muscular dystrophy. New Eng,  J.  Med. 318:1363- 
1368. 
Hoffman, E. P,, S. C. Watkins, H, S. Slayter, and L, M. Kunkel.  1989. Detec- 
tion of a specific isoform of alpha-actinin with antisera directed against dys- 
trophin. J.  Cell Biol.  108:503-510. 
Ibraghimov-Beskrovnaya,  O., J. M. Ervasti, C. J. Leveille, C. A. Slaughter, 
S. W. Semett, and K. P. Campbell.  1992. Primary structure of dystrophin- 
associated glycoproteins linking dyst~ophin to the extracellular  matrix.  Na- 
ture (Lord.).  355:696-702. 
Johnson, G. D., R. S. Davidson,  K. C. McNamee, G. Russell, D. Goodwin, 
and E. J. Holborow. 1982. Fading of irnmunofluorescence during micros- 
copy: a study  of the phenomenon and its remedy. J.  lmmunol.  Methods. 
55:231-242. 
Koenig, M., A. P. Monaco, and L. M. Kunkel.  1988. The complete sequence 
of dystrophin predicts a rod-shaped cytoskeletal protein.  Cell. 53:219-228. 
Laemmli,  U. K. 1970, Cleavage of structural  proteins during the assembly of 
the head of bacteriophage  1"4. Nature (Lond.).  227:680-685. 
Liu, S.-C, L. H. Derick, P. Agre, and J. Palek.  1990. Alteration of  the erythro- 
cyte membrane skeletal ultrastructure in hereditary spherocytosis,  hereditary 
elliptocytosis,  and pyropoikilocytosis.  Blood. 76:198-205. 
Marchesi, V. T. 1985. Stabilizing infrastructure  of cell membranes. Ann.  Rev. 
Cell Biol. 1:531-561. 
Mokri, B.,  and  A. G. Engel. 1975.  Ducbenne dystrophy:  electron  microscopic 
findings  pointing  to  a  basic  or  early  abnormality  in  the  plasma membrane of 
the muscle fiber.  Neurology.  25:1111-1120. 
Morrow, J. 8. 1989.  The spectrin  membrane skeleton:  emerging concepts. 
Curt. Opin.  Cell Biol. 1:23-29. 
Nelson, W. J., and E. Lazarides.  1983. Expression of the/3 subunit of spectrin 
in nonerythroid cells. Proc. Natl. Acad. Sci.  USA.  80:363-367. 
Nelson, W. J., and E. Lazarides.  1984. Goblin (ankyrin)  in striated  muscle: 
identification of the potential membrane receptor for erythroid spectrin in 
muscle cells. Proc. NatL Acad.  Sci.  USA.  81:3292-3296. 
Ohlendieck,  K., J.  M.  Ervasti, I.  B.  Snook,  and K.  P.  Campbell.  1991. 
Dystrophin-glycoprotein  complex is highly enriched in isolated skeletal mus- 
The Journal  of  Cell  Biology,  Volume 117,  1992  1004 cle sarcolemma. J.  Cell Biol.  112:135-148. 
Palek, J., and S. Lambert.  1990. Genetics of the red cell membrane skeleton. 
Sere. Hematol.  27:290-332. 
Pardo, J. V., J. D. Siliciano,  and S. W. Craig.  1983a.  A vinculin-containing 
cortical  lattice in skeletal muscle: transverse lattice elements ("costameres") 
mark sites of attachment between myofibrils and sarcolemma. Proc. Natl. 
Acad.  Sci.  USA.  80:1008-1012. 
Pardo, J. V., J. D. Siliciano,  and S. W. Craig. 1983b. Vinculin is a component 
of an extensive network of myofibril-sarcolemma attachment regions in 
cardiac muscle fibers.  J.  Cell Biol.  97:1081-1088. 
Pierobon-Bormioli, S.  1981.  Transverse sarcomere filamentous systems: 'Z- 
and M-cables'. J. Mus. Res.  Cell Motil.  2:401-413. 
Pons, F., N. Augier, J. O. C. I.~ger, A. Robert, F. M. S. Tomt, M. Fardeau, 
T. Voit, L. V. B. Nicholson, D. Mornet, and J. J. l.~ger.  1991. A homo- 
logue of dystrophin is expressed at the neuromuscular  junctions of normal 
individuals and DMD patients, and of normal and mdx mice. FEBS (Fed. 
Fur. Biochem.  Soc.) Lett.  282:161-165. 
Repasky, E. A., B. L. Granger, and E. Lazarides. 1982. Widespread occur- 
rence of avian spectrin in nonerythroid cells. Cell.  29:821-833. 
Saga, S., M. Hamaguchi, M. Hoshino, and K. Kojima. 1985.  Expression of 
meta-vinculin associated with differentiation  of chicken embryonal muscle 
cells. Exp.  Cell Res.  156:45-56. 
Sanes, J.  R.  1982.  Laminin, fibronectin,  and collagen in  syanptic and ex- 
trasynaptic portions of muscle fiber  basement membrane. J.  Cell BioL 
93:442-451. 
Sealock,  R., M. H. Butler, N. R. Kramarcy, K.-X Gao, A. A. Murnane, K. 
Douville, and S. C. Froehner.  1991. Localization of dystrophin relative to 
acetylcholine receptor domains in electric tissue and adult and cultured skele- 
tal muscle. J.  Cell Biol.  113:1133-1144. 
Shear, C. R., and R. J. Bitch. 1985. Vinculin in subsarcolemmal densities in 
chicken skeletal muscle: localization and relationship to intracellular and ex- 
tracellular structures. J.  Cell Biol.  101:240-256. 
Shimizu, T,, K. Matsumura, Y.  Sunada, and T. Mannen.  1989.  Dense im- 
munostainings  on both neuromuscular  and myotendon  junctions with an anti- 
dystrophin monoclonal antibody. Biomed.  Res.  10:405--409. 
Street,  S. F. 1983. Lateral transmission of tension in frog myofibers: a myofi- 
brillar network and transverse cytoskeletal connections  are possible transmit- 
ters. J.  Cell. Physiol.  114:346-364. 
Terracio, L., D. Gullberg, K. Rubin, S. Craig, and T. K. Borg. 1989. Expres- 
sion of collagen adhesion proteins and their association with the cytoskeleton 
in cardiac myocytes. Anat. Rec.  223:62-71. 
Terracio, L., D. G. Simpson, L. I-lilenski, W. Carver, R. S. Decker, N. Vin- 
son, and T. K. Borg. 1990. Distribution of vinculin in the Z-disk of striated 
muscle: analysis by laser scanning confocal microscopy. J.  Cell.  Physiol. 
145:78-87. 
Tidball,  J. G., and D. J.  Law.  1991.  Dystrophin is required for normal thin 
filament-membrane  associations at myotendinous  junctions. Am. J. Pathol. 
138:17-21. 
Torres, L. F. B., and L. W. Duchen. 1987. The mutant nu/x: inherited myopa- 
thy in the mouse. Brain.  110:269-299. 
Wakayama, Y.,  and S.  Shibuya.  1990.  Observations on the muscle plasma 
membrane-associated  cytoskeletons of mdx mice by quick-freeze, deep-etch, 
rotory-shadow replica  method. Acta.  Neuropathol.  80:618-623. 
Wakayama, Y., and S. Shibuya.  1991.  Gold-labelled  dystrophin molecule in 
muscle plasmalemma of mdx control mice as seen by electron microscopy 
of deep etching replica.  Acta Neuropathol.  82:178-184. 
Watldns, S. C., E. P. Hoffman, H. S. Slayter, and L. M. Kunkel. 1988. Immu- 
ncelectron microscopic  localization  of dystrophin in  myofibres. Nature 
(Lond,).  333:863-866. 
Webster, C., L. Silberstein, A. P. Hays, and H. M. Blau.  1988.  Fast muscle 
fibers are preferentially affected in Duchenne muscular dystrophy. Cell. 52: 
503-513. 
WeUer, P. A., E. P. Ogryzko, E. B. Corben, N. I. Zhidkova, B. Patel, G. J. 
Price, N. K. Spurr, V. E. Koteliansky, andD. R. Critchiey. 1990. Complete 
sequence of human vinculin and assignment  of the gene to chromosome 10. 
Proc.  Natl.  Acad.  Sci.  USA. 87:5667-5671. 
Winkelmann, J. C., L-G Chang, W. T. Tse, A. L. Scarpa,  V. T. Marehesi, 
and B.  G.  Forget.  1990a.  Full length sequence of the eDNA for human 
erythroid/3-spectrin. J. Biol.  Chem.  265:11827-11832. 
Winkelmann,  J. C., F. F. Costa, B. L. Linzie, and B. G. Forget. 1990b./5 Spec- 
trin in human skeletal muscle: tissue-specific differential  processing of 3'/5 
spectrin pre-mRNA generates a/5 spectrin isoform with a unique carboxyl 
terminus. J. Biol.  Chem.  265:20449-20454. 
Wolf, D.  E.  1988.  Probing the lateral  organization and dynamics of mem- 
branes. In Spectroscopic Membrane Probes.  L.  M.  Loew,  editor.  CRC 
Press, Boca Raton, FL.  193-220. 
Yeadon, L  E., H. Lin, S. M. Dyer, and S. J. Burden. 1991.  Dystrophin is a 
component of the subsynaptic membrane. J.  Cell Biol.  115:1069-1076. 
Yoshida, M., and E. Ozawa.  1990.  Glycoprotein complex anchoring dystro- 
phin to sarcolemma. J. Biochem.  108:748-752. 
Zubrzycka-Gaarn, E. E., D. E. Bulman, G. Karpati, A. H. M. Burghes, B. 
Belfall, H. J. Klamut, J. Talbot, R. S. Hodges, P. N. Ray, and R. G. Wor- 
ton.  1988. The Ducbenne muscular dystrophy gene product is localized in 
sarcolemma of human skeletal  muscle. Nature (Lond.).  333:466-469. 
Porter et al. Dystrophin and Spectrin in Costameres of Skeletal Mu,~cle  1005 